Harnessing Data to Transform How Medicines Are Developed, Commercialized, and Reimbursed

Share on facebook
Share on twitter
Share on linkedin
Digital Health Data

Snowflake Cost Saving

We Automate SnowflakeDB Data Cloud Cost Saving. Sign Our Free 7 Days No Risk Trail Now

Presentation Description:

The life sciences industry is under tremendous pressure from declining R&D productivity, mounting pricing pressures, and an increasing demand for evidence. Life science organizations are developing new capabilities to manage and analyze the growing amount of digital health data generated by the healthcare ecosystem to inform key decisions across the product life cycle. Join this session to learn about emerging trends in the use of digital health data and the evolution of advanced analytics and technology platforms.

Presentation Track: Industry Solutions Spotlight
Presentation Date: November 29, 2020
Presentation Speaker(s): Jeffrey Morgan
Frank’s Comment: Hey – I have one of my best friends from High School that is from Deloitte so I’m not going to diss this. You never know it might be good.

Overview ITS:

This session speaks on the emerging trends in the use of digital health daata and the evolution of advanced analytics and technology platforms. Explaining the pressure of the life science industry with mounting pricing pressures, growing demands for evidence, and declining R&D productivity, Jeffrey Morgan emphasizes the importance of unlocking value through the harnessing and democratization of data. Doing so will not only accelerate drug development, but improve evidence generation that supports payer, provider, and patient needs.
[site_reviews_form assigned_posts="post_id" hide="title,name,email"]
[site_reviews_summary assigned_posts="post_id"]